FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898486570> ?p ?o ?g. }

• W2898486570 endingPage "549" @default.
• W2898486570 startingPage "539" @default.
• W2898486570 abstract "Abstract Background Existing data on the clinical features and outcomes of immunocompromised children with influenza are limited. Methods Data from the 2011–2012 through 2014–2015 influenza seasons were collected as part of the Centers for Disease Control and Prevention (CDC) Influenza Hospitalization Surveillance Network (FluSurv-NET). We compared clinical features and outcomes between immunocompromised and nonimmunocompromised children (&lt;18 years old) hospitalized with laboratory-confirmed community-acquired influenza. Immunocompromised children were defined as those for whom ≥1 of the following applies: human immunodeficiency virus/acquired immunodeficiency syndrome, cancer, stem cell or solid organ transplantation, nonsteroidal immunosuppressive therapy, immunoglobulin deficiency, complement deficiency, asplenia, and/or another rare condition. The primary outcomes were intensive care admission, duration of hospitalization, and in-hospital death. Results Among 5262 hospitalized children, 242 (4.6%) were immunocompromised; receipt of nonsteroidal immunosuppressive therapy (60%), cancer (39%), and solid organ transplantation (14%) were most common. Immunocompromised children were older than the nonimmunocompromised children (median, 8.8 vs 2.8 years, respectively; P &lt; .001), more likely to have another comorbidity (58% vs 49%, respectively; P = .007), and more likely to have received an influenza vaccination (58% vs 39%, respectively; P &lt; .001) and early antiviral treatment (35% vs 27%, respectively; P = .013). In multivariable analyses, immunocompromised children were less likely to receive intensive care (adjusted odds ratio [95% confidence interval], 0.31 [0.20–0.49]) and had a slightly longer duration of hospitalization (adjusted hazard ratio of hospital discharge [95% confidence interval], 0.89 [0.80–0.99]). Death was uncommon in both groups. Conclusions Immunocompromised children hospitalized with influenza received intensive care less frequently but had a longer hospitalization duration than nonimmunocompromised children. Vaccination and early antiviral use could be improved substantially. Data are needed to determine whether immunocompromised children are more commonly admitted with milder influenza severity than are nonimmunocompromised children." @default.
• W2898486570 created "2018-11-02" @default.
• W2898486570 creator A5000460434 @default.
• W2898486570 creator A5002177202 @default.
• W2898486570 creator A5002620118 @default.
• W2898486570 creator A5011151803 @default.
• W2898486570 creator A5019874136 @default.
• W2898486570 creator A5026869045 @default.
• W2898486570 creator A5026918647 @default.
• W2898486570 creator A5037823851 @default.
• W2898486570 creator A5040127777 @default.
• W2898486570 creator A5045847408 @default.
• W2898486570 creator A5046477745 @default.
• W2898486570 creator A5049013080 @default.
• W2898486570 creator A5057268352 @default.
• W2898486570 creator A5060055972 @default.
• W2898486570 creator A5071203435 @default.
• W2898486570 creator A5074975869 @default.
• W2898486570 creator A5078442226 @default.
• W2898486570 creator A5078943551 @default.
• W2898486570 creator A5079489250 @default.
• W2898486570 creator A5089135490 @default.
• W2898486570 date "2018-10-25" @default.
• W2898486570 modified "2023-10-14" @default.
• W2898486570 title "Clinical Features and Outcomes of Immunocompromised Children Hospitalized With Laboratory-Confirmed Influenza in the United States, 2011–2015" @default.
• W2898486570 cites W1978959016 @default.
• W2898486570 cites W1984679171 @default.
• W2898486570 cites W2028806345 @default.
• W2898486570 cites W2056323813 @default.
• W2898486570 cites W2068789594 @default.
• W2898486570 cites W2080636255 @default.
• W2898486570 cites W2081886139 @default.
• W2898486570 cites W2096991747 @default.
• W2898486570 cites W2127005977 @default.
• W2898486570 cites W2132922192 @default.
• W2898486570 cites W2135916938 @default.
• W2898486570 cites W2137119009 @default.
• W2898486570 cites W2138030172 @default.
• W2898486570 cites W2154219907 @default.
• W2898486570 cites W2155417283 @default.
• W2898486570 cites W2167428475 @default.
• W2898486570 cites W2168360824 @default.
• W2898486570 cites W2169491330 @default.
• W2898486570 cites W2177992730 @default.
• W2898486570 cites W2213335124 @default.
• W2898486570 cites W2560983642 @default.
• W2898486570 cites W2616790117 @default.
• W2898486570 cites W2796377403 @default.
• W2898486570 cites W4248190493 @default.
• W2898486570 doi "https://doi.org/10.1093/jpids/piy101" @default.
• W2898486570 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30358877" @default.
• W2898486570 hasPublicationYear "2018" @default.
• W2898486570 type Work @default.
• W2898486570 sameAs 2898486570 @default.
• W2898486570 citedByCount "13" @default.
• W2898486570 countsByYear W28984865702019 @default.
• W2898486570 countsByYear W28984865702020 @default.
• W2898486570 countsByYear W28984865702021 @default.
• W2898486570 countsByYear W28984865702022 @default.
• W2898486570 countsByYear W28984865702023 @default.
• W2898486570 crossrefType "journal-article" @default.
• W2898486570 hasAuthorship W2898486570A5000460434 @default.
• W2898486570 hasAuthorship W2898486570A5002177202 @default.
• W2898486570 hasAuthorship W2898486570A5002620118 @default.
• W2898486570 hasAuthorship W2898486570A5011151803 @default.
• W2898486570 hasAuthorship W2898486570A5019874136 @default.
• W2898486570 hasAuthorship W2898486570A5026869045 @default.
• W2898486570 hasAuthorship W2898486570A5026918647 @default.
• W2898486570 hasAuthorship W2898486570A5037823851 @default.
• W2898486570 hasAuthorship W2898486570A5040127777 @default.
• W2898486570 hasAuthorship W2898486570A5045847408 @default.
• W2898486570 hasAuthorship W2898486570A5046477745 @default.
• W2898486570 hasAuthorship W2898486570A5049013080 @default.
• W2898486570 hasAuthorship W2898486570A5057268352 @default.
• W2898486570 hasAuthorship W2898486570A5060055972 @default.
• W2898486570 hasAuthorship W2898486570A5071203435 @default.
• W2898486570 hasAuthorship W2898486570A5074975869 @default.
• W2898486570 hasAuthorship W2898486570A5078442226 @default.
• W2898486570 hasAuthorship W2898486570A5078943551 @default.
• W2898486570 hasAuthorship W2898486570A5079489250 @default.
• W2898486570 hasAuthorship W2898486570A5089135490 @default.
• W2898486570 hasConcept C121608353 @default.
• W2898486570 hasConcept C126322002 @default.
• W2898486570 hasConcept C156957248 @default.
• W2898486570 hasConcept C187212893 @default.
• W2898486570 hasConcept C207103383 @default.
• W2898486570 hasConcept C2780252810 @default.
• W2898486570 hasConcept C2911091166 @default.
• W2898486570 hasConcept C44249647 @default.
• W2898486570 hasConcept C71924100 @default.
• W2898486570 hasConceptScore W2898486570C121608353 @default.
• W2898486570 hasConceptScore W2898486570C126322002 @default.
• W2898486570 hasConceptScore W2898486570C156957248 @default.
• W2898486570 hasConceptScore W2898486570C187212893 @default.
• W2898486570 hasConceptScore W2898486570C207103383 @default.
• W2898486570 hasConceptScore W2898486570C2780252810 @default.
• W2898486570 hasConceptScore W2898486570C2911091166 @default.
• W2898486570 hasConceptScore W2898486570C44249647 @default.

• next